Skip directly to site content Skip directly to search
Español | Other Languages
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
Mpox
    CDC Home

    Special Population Considerations

    Print
    Minus
    Related Pages
    • baby iconPeople Who Are Pregnant or Breastfeeding
    • preschool iconChildren and Adolescents
    • pills iconPeople Who Have HIV or Are Immunocompromised
    • eye iconClinical Considerations for Ocular Infection
    Last Reviewed: August 31, 2023
    Source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP)
    • Facebook
    • Twitter
    • LinkedIn
    • Syndicate
    homeMpox
    • Your Healthplus icon
      • Signs & Symptoms
      • How It Spreads
      • Testing
      • Preventionplus icon
        • Protect Yourself
        • Mpox and HIV
        • Safer Sex & Social Gatherings
        • Congregate Settings
      • Vaccinesplus icon
        • Mpox Vaccine Recommendations
      • Mpox Infections after Vaccination
      • If You're a Close Contact
      • If You Are Sickplus icon
        • What to Do If You Are Sick
        • Prevent Spread to Others
        • Patient's Guide to Tecovirimat
        • Cleaning and Disinfecting
      • About Mpox
    • 2022-2023 Outbreak Cases & Dataplus icon
      • 2022-2023 U.S. Map & Case Count
      • U.S. Case Trends
      • 2022-2023 Global Map & Case Count
      • Vaccine Administration & Effectivenessplus icon
        • Vaccine Administration Data
        • Vaccine Administration U.S. Map
        • JYNNEOS Vaccine Coverage
        • JYNNEOS Vaccine Effectiveness
      • Laboratory Testing Data
      • Case Demographics
      • Past U.S. Cases & Outbreaks
    • Healthcare Professionalsplus icon
      • Case Definition
      • Clinical Guidanceplus icon
        • Clinical Recognition
        • Clinical Treatment
        • Pain Management
        • Clinician Fact Sheet: VIRISMAP
        • Tecovirimat
        • Tecovirimat IND
      • Special Population Considerationsplus icon
        • Pregnancy Considerations
        • Pediatric Considerations
        • Considerations for People with HIV
        • Considerations for Ocular Infection
      • Vaccination Basics for Healthcare Professionals
      • Vaccine Considerationsplus icon
        • Components of the U.S. National Vaccination Strategy
        • JYNNEOS
        • ACAM2000
        • Specific Populations
        • Errors and Deviations
      • Provider Agreement
      • Specimen Collectionplus icon
        • Biopsy of Severe Infections
      • Infection Controlplus icon
        • Infection Control in Healthcare Settings
        • Isolation & Infection Control at Home
        • Autopsy & Handling of Human Remains
      • Completing Death Certificates
    • Laboratoriesplus icon
      • Laboratory Biosafety
      • How to Report Test Results
    • Health Departmentsplus icon
      • Case Reporting
      • Vaccine Equity Program
    • Veterinariansplus icon
      • Mpox in Animals & Pets
      • For Public Health Veterinarians & Animal Health Officials
      • Examining Animals with Suspected Mpox
      • Case Definitions for Animals
    • Communication Resourcesplus icon
      • Digital Resources
      • Social Media Toolkit
    • What’s New & Updated
    • About CDC
    • Contact Us
    • 800-232-4636
    Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
    CONTACT CDC
    Contact Us
    Call 800-232-4636
    Email Us
    ABOUT CDC
    • About CDC
    • Jobs
    • Funding
    POLICIES
    • Accessibility
    • External Links
    • Privacy
    • Policies
    • No Fear Act
    • FOIA
    • OIG
    • Nondiscrimination
    • Vulnerability Disclosure Policy
    CONNECT WITH US
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Youtube
    • Pinterest
    • Snapchat
    • Email
    LANGUAGES
    • Español
    • 繁體中文
    • Tiếng Việt
    • 한국어
    • Tagalog
    • Русский
    • العربية
    • Kreyòl Ayisyen
    • Français
    • Polski
    • Português
    • Italiano
    • Deutsch
    • 日本語
    • فارسی
    • English
    • U.S. Department of Health & Human Services
    • Accessibility
    • External Links
    • Privacy
    • Policies
    • No Fear Act
    • FOIA
    • Nondiscrimination
    • OIG
    • Vulnerability Disclosure Policy
    • USA.gov
    SAS stats

    Exit Notification / Disclaimer Policy

    Links with this icon indicate that you are leaving the CDC website.
    • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
    • Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
    • You will be subject to the destination website's privacy policy when you follow the link.
    • CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
    For more information on CDC's web notification policies, see Website Disclaimers.